icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Analysis of Sustained Viral Response and Boceprevir Resistance Following Combination Treatment With Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in HCV Genotype 1 Prior Relapsers And Nonresponders
 
 
  Reported by Jules Levin
AASLD Nov 5-8 2011 SF
 
J Howe1, R Ogert1, R Barnard1, D Hazuda1, LD Pedicone1, CA Brass1, JK Albrecht1, and S Flamm2
 
1Merck, Sharp & Dohme Corp., Whitehouse Station, NJ; 2Northwestern Feinberg School of Medicine, Chicago, IL

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif

AASLD14.gif